PROMIS NEUROSCIENCES INC. Shares Issued
PROMIS NEUROSCIENCES INC. (PMN) had Shares Issued of 8.97 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-13
- 2026-06-30: Common Stock, Shares, Issued 8.97M shares.
- 2026-03-31: Common Stock, Shares, Issued 8.97M shares.
- 2025-12-31: Common Stock, Shares, Issued 2.15M shares.
- 2025-09-30: Common Stock, Shares, Issued 53.81M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 8.97M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 8.97M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 2.15M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 53.81M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 32.69M shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 32.69M shares 10-Q · filed 2025-05-12 | |
| 2024-12-31 | 1.31M shares 10-K · filed 2026-03-25 | 32.69M shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 32.69M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 18.96M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 18.96M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 18.89M shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 18.53M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 8.58M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 8.58M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 8.58M shares 10-K · filed 2024-04-01 | |
| 2022-09-30 | 7.20M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 7.20M shares 10-Q · filed 2022-08-12 | |
| 2021-12-31 | 7.20M shares 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |